498 related articles for article (PubMed ID: 23932636)
1. Detection and classification of different liver lesions: comparison of Gd-EOB-DTPA-enhanced MRI versus multiphasic spiral CT in a clinical single centre investigation.
Böttcher J; Hansch A; Pfeil A; Schmidt P; Malich A; Schneeweiss A; Maurer MH; Streitparth F; Teichgräber UK; Renz DM
Eur J Radiol; 2013 Nov; 82(11):1860-9. PubMed ID: 23932636
[TBL] [Abstract][Full Text] [Related]
2. Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease.
Ichikawa T; Saito K; Yoshioka N; Tanimoto A; Gokan T; Takehara Y; Kamura T; Gabata T; Murakami T; Ito K; Hirohashi S; Nishie A; Saito Y; Onaya H; Kuwatsuru R; Morimoto A; Ueda K; Kurauchi M; Breuer J
Invest Radiol; 2010 Mar; 45(3):133-41. PubMed ID: 20098330
[TBL] [Abstract][Full Text] [Related]
3. Accuracy and confidence of Gd-EOB-DTPA enhanced MRI and diffusion-weighted imaging alone and in combination for the diagnosis of liver metastases.
Donati OF; Fischer MA; Chuck N; Hunziker R; Weishaupt D; Reiner CS
Eur J Radiol; 2013 May; 82(5):822-8. PubMed ID: 23287713
[TBL] [Abstract][Full Text] [Related]
4. Value of retrospective fusion of PET and MR images in detection of hepatic metastases: comparison with 18F-FDG PET/CT and Gd-EOB-DTPA-enhanced MRI.
Donati OF; Hany TF; Reiner CS; von Schulthess GK; Marincek B; Seifert B; Weishaupt D
J Nucl Med; 2010 May; 51(5):692-9. PubMed ID: 20395324
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of MR imaging with liver-specific contrast agent: U.S. multicenter phase III study.
Bluemke DA; Sahani D; Amendola M; Balzer T; Breuer J; Brown JJ; Casalino DD; Davis PL; Francis IR; Krinsky G; Lee FT; Lu D; Paulson EK; Schwartz LH; Siegelman ES; Small WC; Weber TM; Welber A; Shamsi K
Radiology; 2005 Oct; 237(1):89-98. PubMed ID: 16126918
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic performance and description of morphological features of focal nodular hyperplasia in Gd-EOB-DTPA-enhanced liver magnetic resonance imaging: results of a multicenter trial.
Zech CJ; Grazioli L; Breuer J; Reiser MF; Schoenberg SO
Invest Radiol; 2008 Jul; 43(7):504-11. PubMed ID: 18580333
[TBL] [Abstract][Full Text] [Related]
7. Diffusion weighted imaging of liver lesions suspect for metastases: Apparent diffusion coefficient (ADC) values and lesion contrast are independent from Gd-EOB-DTPA administration.
Benndorf M; Schelhorn J; Dietzel M; Kaiser WA; Baltzer PA
Eur J Radiol; 2012 Aug; 81(8):e849-53. PubMed ID: 22575171
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic efficacy of gadoxetic acid (Primovist)-enhanced MRI and spiral CT for a therapeutic strategy: comparison with intraoperative and histopathologic findings in focal liver lesions.
Hammerstingl R; Huppertz A; Breuer J; Balzer T; Blakeborough A; Carter R; Fusté LC; Heinz-Peer G; Judmaier W; Laniado M; Manfredi RM; Mathieu DG; Müller D; Mortelè K; Reimer P; Reiser MF; Robinson PJ; Shamsi K; Strotzer M; Taupitz M; Tombach B; Valeri G; van Beers BE; Vogl TJ;
Eur Radiol; 2008 Mar; 18(3):457-67. PubMed ID: 18058107
[TBL] [Abstract][Full Text] [Related]
9. Additional value of gadoxetic acid-DTPA-enhanced hepatobiliary phase MR imaging in the diagnosis of early-stage hepatocellular carcinoma: comparison with dynamic triple-phase multidetector CT imaging.
Haradome H; Grazioli L; Tinti R; Morone M; Motosugi U; Sano K; Ichikawa T; Kwee TC; Colagrande S
J Magn Reson Imaging; 2011 Jul; 34(1):69-78. PubMed ID: 21598343
[TBL] [Abstract][Full Text] [Related]
10. Application of classification trees for the qualitative differentiation of focal liver lesions suspicious for metastasis in gadolinium-EOB-DTPA-enhanced liver MR imaging.
Schelhorn J; Benndorf M; Dietzel M; Burmeister HP; Kaiser WA; Baltzer PA
Rofo; 2012 Sep; 184(9):788-94. PubMed ID: 22618476
[TBL] [Abstract][Full Text] [Related]
11. Imaging features of intrahepatic cholangiocarcinoma in Gd-EOB-DTPA-enhanced MRI.
Péporté AR; Sommer WH; Nikolaou K; Reiser MF; Zech CJ
Eur J Radiol; 2013 Mar; 82(3):e101-6. PubMed ID: 23159401
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic performance of gadoxetic acid-enhanced liver MRI versus multidetector CT in the assessment of colorectal liver metastases compared to hepatic resection.
Granata V; Fusco R; de Lutio di Castelguidone E; Avallone A; Palaia R; Delrio P; Tatangelo F; Botti G; Grassi R; Izzo F; Petrillo A
BMC Gastroenterol; 2019 Jul; 19(1):129. PubMed ID: 31340755
[TBL] [Abstract][Full Text] [Related]
13. Detection of hepatocellular carcinoma by Gd-EOB-DTPA-enhanced liver MRI: comparison with triple phase 64 detector row helical CT.
Akai H; Kiryu S; Matsuda I; Satou J; Takao H; Tajima T; Watanabe Y; Imamura H; Kokudo N; Akahane M; Ohtomo K
Eur J Radiol; 2011 Nov; 80(2):310-5. PubMed ID: 20732773
[TBL] [Abstract][Full Text] [Related]
14. Hepatocellular carcinoma in patients with chronic liver disease: a comparison of gadoxetic acid-enhanced MRI and multiphasic MDCT.
Baek CK; Choi JY; Kim KA; Park MS; Lim JS; Chung YE; Kim MJ; Kim KW
Clin Radiol; 2012 Feb; 67(2):148-56. PubMed ID: 21920517
[TBL] [Abstract][Full Text] [Related]
15. Gadoxetate disodium-enhanced magnetic resonance imaging versus contrast-enhanced 18F-fluorodeoxyglucose positron emission tomography/computed tomography for the detection of colorectal liver metastases.
Seo HJ; Kim MJ; Lee JD; Chung WS; Kim YE
Invest Radiol; 2011 Sep; 46(9):548-55. PubMed ID: 21577131
[TBL] [Abstract][Full Text] [Related]
16. Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA.
Vogl TJ; Kümmel S; Hammerstingl R; Schellenbeck M; Schumacher G; Balzer T; Schwarz W; Müller PK; Bechstein WO; Mack MG; Söllner O; Felix R
Radiology; 1996 Jul; 200(1):59-67. PubMed ID: 8657946
[TBL] [Abstract][Full Text] [Related]
17. Contrast agent Gd-EOB-DTPA (EOB·Primovist®) for low-field magnetic resonance imaging of canine focal liver lesions.
Yonetomi D; Kadosawa T; Miyoshi K; Nakao Y; Homma E; Hanazono K; Yamada E; Nakamura K; Ijiri A; Minegishi N; Maetani S; Hirayama K; Taniyama H; Nakade T
Vet Radiol Ultrasound; 2012; 53(4):371-80. PubMed ID: 22548505
[TBL] [Abstract][Full Text] [Related]
18. [Gd-EOB-DTPA-enhanced magnetic resonance imaging: differentiation between focal nodular hyperplasia and hepatocellular adenoma].
Portilha MA; Pedro MT; Ruivo C; Semedo LC; Marques C; Alves FC
Acta Med Port; 2011 Dec; 24 Suppl 2():531-8. PubMed ID: 22849944
[TBL] [Abstract][Full Text] [Related]
19. Gadoxetic acid-enhanced magnetic resonance imaging for differentiating small hepatocellular carcinomas (< or =2 cm in diameter) from arterial enhancing pseudolesions: special emphasis on hepatobiliary phase imaging.
Sun HY; Lee JM; Shin CI; Lee DH; Moon SK; Kim KW; Han JK; Choi BI
Invest Radiol; 2010 Feb; 45(2):96-103. PubMed ID: 20057319
[TBL] [Abstract][Full Text] [Related]
20. Hepatocellular carcinoma in a North American population: does hepatobiliary MR imaging with Gd-EOB-DTPA improve sensitivity and confidence for diagnosis?
Bashir MR; Gupta RT; Davenport MS; Allen BC; Jaffe TA; Ho LM; Boll DT; Merkle EM
J Magn Reson Imaging; 2013 Feb; 37(2):398-406. PubMed ID: 23011874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]